Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
Completed · Phase 2
Conditions studied: Cholangiocarcinoma, Gallbladder Cancer
In brief
To determine the activity of gemcitabine combined with carboplatin in the treatment of patients with metastatic or recurrent cholangiocarcinoma or gallbladder cancer.
Key facts
- Study ID
- NCT00660140
- Run by
- Washington University School of Medicine
- People needed
- 49
- Starts
- 2002-03-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2013-08-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington University School of Medicine — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.